Report overview
Report Overview
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
The global Pet NSAIDs market size was estimated at USD 35 million in 2023 and is projected to reach USD 50.25 million by 2032, exhibiting a CAGR of 4.10% during the forecast period.
North America Pet NSAIDs market size was estimated at USD 9.77 million in 2023, at a CAGR of 3.51% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Pet NSAIDs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pet NSAIDs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pet NSAIDs market in any manner.
Global Pet NSAIDs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zoetis
Elanco
PREVICOX
Metacam
Chanelle Pharma
AVENTIX
Woodruff
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
Vethical
Vetoquinol
Pivetal
Market Segmentation (by Type)
Carprofen
Deracoxib
Firocoxib
Meloxicam
Market Segmentation (by Application)
Dog
Cat
Horse
Others
Geographic Segmentation
